A Study of 3 Biotechs – a Story of Hope, Potential and Partnerships

A Study Of 3 Biotechs – A Story Of Hope, Potential And Partnerships
Athersys has a trial for MultiStem for use in patients suffering from ischemic stroke and also a trail going with Pfizer (PFE) for patients suffering from ulcerative colitis. Both are in Stage II clinical studies. Athersys has also submitted plans to … Read more on Seeking Alpha

The Stem Cell Revolution Can Jump-Start Your Portfolio: Jason Kolbert
In addition to heart disease, Mesoblast is pursuing degenerative disc disease (DDD) and spinal fusion, both local indications, and systemically, type 2 diabetes and rheumatoid arthritis, all with its mesenchymal precursor cells (MPCs). Athersys is … Read more on Trefis

Health care researchers aim to harness signals
“The real dream for the research, at least for people with brain stem stroke or cervical , would be to one day reconnect brain to limb, take these signals out of the brain and root them back down to stimulating electrodes elsewhere in … Read more on The Augusta Chronicle


Tags: , , ,